Aligos Therapeutics 배당금
배당금 기준 확인 0/6
Aligos Therapeutics does not have a record of paying a dividend.
주요 정보
n/a
배당 수익률
-30.3%
환매 수익률
총 주주 수익률 | -30.3% |
미래 배당 수익률 | n/a |
배당금 성장 | n/a |
다음 배당금 지급일 | n/a |
전 배당일 | n/a |
주당 배당금 | n/a |
지급 비율 | n/a |
최근 배당금 업데이트
업데이트 없음
Recent updates
Aligos Therapeutics, Inc. (NASDAQ:ALGS) Stock Catapults 49% Though Its Price And Business Still Lag The Industry
Jul 31Aligos Therapeutics (NASDAQ:ALGS) Will Have To Spend Its Cash Wisely
Jul 16Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) 27% Dip In Price Shows Sentiment Is Matching Revenues
May 24Aligos Therapeutics, Inc. (NASDAQ:ALGS) Stock Catapults 27% Though Its Price And Business Still Lag The Industry
Apr 09Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) Share Price Is Matching Sentiment Around Its Revenues
Feb 23Here's Why We're Watching Aligos Therapeutics' (NASDAQ:ALGS) Cash Burn Situation
Oct 24We Think Aligos Therapeutics (NASDAQ:ALGS) Needs To Drive Business Growth Carefully
Jul 17We Think Aligos Therapeutics (NASDAQ:ALGS) Needs To Drive Business Growth Carefully
Mar 11Aligos Therapeutics begins 12-week dosing in phase 1b study to treat hepatitis B
Jul 25We're Keeping An Eye On Aligos Therapeutics' (NASDAQ:ALGS) Cash Burn Rate
Jul 11We're Keeping An Eye On Aligos Therapeutics' (NASDAQ:ALGS) Cash Burn Rate
Feb 02Here's Why We're Not Too Worried About Aligos Therapeutics' (NASDAQ:ALGS) Cash Burn Situation
Oct 19Aligos Therapeutics EPS beats by $0.16
May 10We're Hopeful That Aligos Therapeutics (NASDAQ:ALGS) Will Use Its Cash Wisely
May 01What Is The Ownership Structure Like For Aligos Therapeutics, Inc. (NASDAQ:ALGS)?
Jan 16Dosing underway for Aligos Therapeutics' hepatitis B candidate in early-stage study
Oct 30결제의 안정성과 성장
배당금 데이터 가져오기
안정적인 배당: Insufficient data to determine if ALGS's dividends per share have been stable in the past.
배당금 증가: Insufficient data to determine if ALGS's dividend payments have been increasing.
시장 대비 배당 수익률
Aligos Therapeutics 시장 대비 배당 수익률 |
---|
세그먼트 | 배당 수익률 |
---|---|
회사 (ALGS) | n/a |
시장 하위 25% (US) | 1.5% |
시장 상위 25% (US) | 4.5% |
업계 평균 (Biotechs) | 2.2% |
애널리스트 예측 (ALGS) (최대 3년) | n/a |
주목할만한 배당금: Unable to evaluate ALGS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
고배당: Unable to evaluate ALGS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
주주에 대한 수익 배당금
수익 보장: Insufficient data to calculate ALGS's payout ratio to determine if its dividend payments are covered by earnings.
주주에 대한 현금 배당금
현금 흐름 범위: Unable to calculate sustainability of dividends as ALGS has not reported any payouts.